Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03470701 · ClinicalTrials.gov registry record · NA
Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit
A NA study of Hypertension and Cardiovascular Diseases, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 999
- Enrollment target
- 1
- Study location
NCT03470701: Completed NA study of Hypertension and Cardiovascular Diseases, sponsored by Geisinger Clinic.
NCT03470701 is a NA study of Hypertension and Cardiovascular Diseases that has completed, run by Geisinger Clinic. The registered enrollment target is 999 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03470701, a NA study of Hypertension and Cardiovascular Diseases, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 999 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.
Primary Outcome
Includes completion of mailed smartphone urinalysis and clinical labs (urinalysis, albumin/creatinine ratio, or protein/creatinine ratio)
Conditions Studied
Interventions
- OTHER Mailed Urinalysis Smartphone Kit
Study Locations (1)
Pennsylvania
- Geisinger Health System - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 999 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2018-06-19 |
| Phase | NA |
What the finished NCT03470701 record still lists
NCT03470701 is an interventional study that assigns participants to a tested intervention. The registered 999 participants enrollment target is mid-sized for trials with a published cap, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower).
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Mailed Urinalysis Smartphone Kit is the first listed.
NCT03470701 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03470701 about?
NCT03470701 is a clinical study titled "Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit". This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.
What is the current status of trial NCT03470701?
This trial is currently completed. It is a NA study. The enrollment target is 999 participants. The study started on 2018-03-19. Estimated completion is 2018-06-19.
What conditions does trial NCT03470701 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Chronic Kidney Diseases, Albuminuria.
What interventions are being tested in trial NCT03470701?
The interventions under investigation include: Mailed Urinalysis Smartphone Kit (OTHER).
Who is sponsoring clinical trial NCT03470701?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03470701 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03470701's enrollment target sits among peer trials
999 76th of 470 higher than 395 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02986048 · 999 participants
Proton Therapy Patient Registry
- NCT04703244 · 999 participants
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI